Novanta Inc.
Novanta Inc. (Nasdaq: NOVT) supplies proprietary technology components and subsystems to medical, life science, and advanced industrial original equipment manufacturers (OEMs). Its products support applications including minimally invasive and robotic surgery, ophthalmology, laboratory automation, laser materials… From the company’s description.
In fiscal 2025, Novanta Inc. reported revenue of $980.60M, up 3.3% from fiscal 2024, and net income of $53.83M. Its operating margin was 9.6%, and operations generated $64.06M in cash. Over the twelve months to Jul 3, 2026, revenue was $1.03B.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Novanta Inc. does
In the company’s own words
Novanta Inc. (Nasdaq: NOVT) supplies proprietary technology components and subsystems to medical, life science, and advanced industrial original equipment manufacturers (OEMs). Its products support applications including minimally invasive and robotic surgery, ophthalmology, laboratory automation, laser materials processing, robotics, and precision manufacturing. Novanta reports two segments: Automation Enabling Technologies, which generated $500.8 million in 2025 revenue, and Medical Solutions, with $479.8 million. Products include laser scanning systems and sources, precision motion controls, robotic end-of-arm tooling, medical insufflators and endoscopic pumps, imaging and RFID systems, light engines, and operating-room technologies. Most offerings are sold to OEMs, primarily through a direct technical sales force, and integrated into customers’ equipment. Medical markets accounted for approximately 53% of 2025 revenue, with advanced industrial markets contributing approximately 47%. The company reported $980.6 million in total revenue and employed approximately 3,000 people as of December 31, 2025. Founded in 1968, Novanta shifted from a greater focus on semiconductors to supplying technology for medical and advanced industrial markets. Its website is www.novanta.com.
Company details
- Sector
- Information Technology
- Industry (SIC)
- Electronic Equipment
- Headquarters
- BEDFORD, MA
- Fiscal year end
- December
- CIK
- 1076930
- SIC
- 3690
Financial performance, year by year
Fiscal 2013–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Novanta Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Superinvestors in Novanta Inc. · what they did last quarter
Share of each manager’s reported 13F portfolio. Change is in shares held, since the previous quarter.
Largest fund holders · Novanta Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Novanta Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Novanta Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Novanta Inc.'s last four quarterly filings that the numbers alone won't show?”